AVANIR PHARMACEUTICALS [2003] [2005] EQUITY INCENTIVE PLAN RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • December 18th, 2006 • Avanir Pharmaceuticals • Pharmaceutical preparations
This Restricted Stock Purchase Agreement (the “Agreement”) is made as of ___, 200___ (the “Effective Date”) by and between Avanir Pharmaceuticals, a California corporation (the “Company”), and (“Purchaser”).
LEASE RREEF AMERICA REIT II CORP. FFF, a Maryland corporation, Landlord, and AVANIR PHARMACEUTICALS, a California corporation, TenantLease Agreement • December 18th, 2006 • Avanir Pharmaceuticals • Pharmaceutical preparations
The Reference Pages information is incorporated into and made a part of the Lease. In the event of any conflict between any Reference Pages information and the Lease, the Lease shall control. The Lease includes Exhibits A through E, all of which are made a part of the Lease.
EMPLOYMENT AGREEMENTEmployment Agreement • December 18th, 2006 • Avanir Pharmaceuticals • Pharmaceutical preparations • California
This EMPLOYMENT AGREEMENT (“Agreement”), dated as of May 4, 2006 (the “Effective Date”), is made by and between AVANIR Pharmaceuticals, a California corporation (the “Company”), and Michael J. Puntoriero (“Employee”).
AVANIR PHARMACEUTICALS Restricted Stock Unit Grant AgreementRestricted Stock Unit Grant Agreement • December 18th, 2006 • Avanir Pharmaceuticals • Pharmaceutical preparations • California
This Restricted Stock Unit Grant Agreement (the “Agreement”) is dated as of [ ] and is entered into between Avanir Pharmaceuticals, a California corporation (the “Company”), and [ ] (the “Awardee”). Capitalized terms not otherwise defined herein shall have the respective meanings set forth in the Plan.
SUBLEASE AGREEMENT between AVANIR PHARMACEUTICALS as Sublandlord and SIRION THERAPEUTICS, INC. as SubtenantSublease Agreement • December 18th, 2006 • Avanir Pharmaceuticals • Pharmaceutical preparations
THIS SUBLEASE AGREEMENT (“Sublease”) is made as of this 5th day of September, 2006 (the “Effective Date”), by and between AVANIR PHARMACEUTICALS, a California corporation (“Sublandlord”) and SIRION THERAPEUTICS, INC., a North Carolina corporation (“Subtenant”), with Sublandlord and Subtenant hereinafter sometimes referred to collectively as the “Parties” and individually as a “Party”).
CONFIDENTIAL DOCOSANOL DATA TRANSFER & PATENT LICENSE AGREEMENTData Transfer & Patent License Agreement • December 18th, 2006 • Avanir Pharmaceuticals • Pharmaceutical preparations • New York
THIS DOCOSANOL DATA TRANSFER & PATENT LICENSE AGREEMENT is made and entered into as of July 6, 2006 (“Effective Date”) between Avanir Pharmaceuticals, a California corporation (“Avanir”) and Healthcare Brands International Limited of 56 Queen Anne Street, London W1G 8LA (“HBI”).
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “***”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING...Development and License Agreement • December 18th, 2006 • Avanir Pharmaceuticals • Pharmaceutical preparations • New York
THIS DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”, as hereinafter defined) dated as of August 7, 2006 (the “Effective Date”), is by and between Eurand, Inc., incorporated in Nevada with its principal offices at 845 Center Dr., Vandalia, Ohio 45377 (“EURAND”) and Avanir Pharmaceuticals, Inc. incorporated in California with its principal offices at 11388 Sorrento Valley Road, Suite 200, San Diego, CA 92121 (“AVANIR”).
